Second-Line Treatment of Pancreatic Adenocarcinoma: Shedding Light on New Opportunities and Key Talking Points from Clinical Trials

Overview of attention for article published in Clinical and Experimental Gastroenterology, April 2024

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 13 X posts from 13 X users, with an upper bound of 60,989 followers.

RT @OsamaMosalemMD: Excited to share our latest publication touching on second line treatment in #PancreaticCancer. In our review, we highl…

RT @OsamaMosalemMD: Excited to share our latest publication touching on second line treatment in #PancreaticCancer. In our review, we highl…

RT @OsamaMosalemMD: Excited to share our latest publication touching on second line treatment in #PancreaticCancer. In our review, we highl…

RT @OsamaMosalemMD: Excited to share our latest publication touching on second line treatment in #PancreaticCancer. In our review, we highl…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 9 additional X posts.